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A B S T R A C T
Objective: In laparoscopic adnexal surgery the conventional method of removing a mass from the
abdominal cavity in Finland is through a 10-mm-wide lateral abdominal port. The larger the lateral
trocar, the greater the risk of pain, complications and delayed recovery. Here, we assumed that adnexal
mass removal through a 10-mm umbilical port together with 5-mm side trocars would decrease the
postoperative need of analgesics when compared with removal through a 10-mm lateral abdominal port.
Study design: Women scheduled for laparoscopic surgery of a benign adnexal mass were invited to
participate. The participants were randomized into two groups: removal via the transumbilical (TU)
(n = 21) or lateral transabdominal (TA) (n = 21) route. General anesthesia and use of local anesthetics were
standardized. The amount of postoperative opioid (oxycodone) and visual analog scale (VAS) scores for
pain were the primary outcome measures. Secondary outcome measures were nausea/vomiting (VAS
evaluation), time to discharge, peri- and postoperative complications, surgeons' opinions of the
alternative methods and patients’ satisfaction, evaluated via a questionnaire sent six months
postoperatively.
Results: There were no significant differences in the use of opioids or median pain-VAS scores between
the groups during the first 24 h postoperatively. However, in the TU group the amount of women with
very low pain-VAS scores (0–1) during the whole 12-h follow-up time was significantly greater than in
the TA group (4 vs. 0 women p = 0.04). The amounts of nausea and vomiting, and median times to
discharge were similar in both groups. There were no major complications.
Conclusions: Both transumbilical and transabdominal routes of abdominal mass removal during
laparoscopy were feasible and safe. However, the transumbilical route resulted in more women with very
low pain-VAS scores.
© 2017 Elsevier B.V. All rights reserved.
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Minimally invasive laparoscopy is the approach of choice in
gynecologic surgery today. It brings many benefits, such as
decreased pain and enhanced recovery [1–3]. However, there is
always a need to improve practices. Usually, during laparoscopic
adnexal mass surgery the trocar needed for mass removal should
be at least 10 mm wide. The incision often has to be enlarged to
enable the retrieval of any larger mass. The recommendation is
to suture the fascia of any incision of 10 mm, to avoid herniation
[4–8]. The risk is low (0.18–0.6/1000) [4,5,9], but trocar hernias at* Corresponding author at: Women's Hospital, Department of Obstetrics and
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0301-2115/© 2017 Elsevier B.V. All rights reserved.extra-umbilical locations represent most (75%) cases [7,10]. The
fascia of a 5-mm incision does not need to be closed because of the
minimal risk of herniation [6]. In cases of 10-mm incisions, sutures
are usually applied using a special endosuture needle to pass the
thread through the fascia edges. The pain increases, the further the
sutures are placed apart. Despite local infiltration of anesthetic,
wound pain may delay recovery [10,11]. Additionally, puncture of
the epigastric artery, or its branch, is a concern when using larger
lateral trocars [9,12,13].
Adnexal mass removal from the abdominal cavity may
alternatively be performed by using suprapubic [15,16], umbilical
or vaginal pathways [17–20]. Unlike in urological or gastrointesti-
nal surgery, evidence for the feasibility of transumbilical mass
retrieval in gynecology is sparse. Because umbilical opening
requires only a vertical incision into the fascia and rectus sheath,
the risk of blood vessel lesion is minimal. Sutures can be easily
placed near the edges of the fascia to avoid extra tension, even if a
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laparoscopic surgery [14,21]. In transumbilical surgery additional
trocars needed may be only 5 mm wide.
The purpose of this study was to compare transumbilical and
lateral transabdominal laparoscopic removal of benign adnexal
masses. Our main hypothesis was that by removing tissue through
a 10-mm umbilical port instead of a 10-mm lateral abdominal port
we could decrease postoperative pain. The primary outcome
measures were the need of postoperative opioids (oxycodone) and
severity of postoperative pain. Secondary outcomes were postop-
erative nausea, length of hospital stay, complications, and patients’
and gynecologists’ opinions of the methods used.
Materials and methods
This randomized prospective trial was conducted at Kätilöo-
pisto Maternity Hospital, Helsinki University Hospital, between
November 2014 and May 2015. Altogether, 42 women scheduled
for adnexal laparoscopy, such as for unilateral or bilateral ovarian
cystectomy, salpingectomy, oophorectomy or salpingo-oophorec-
tomy, agreed to participate in the study (Fig. 1–flow chart). Written
informed consent was obtained from all women. Background
information including age, body mass index (BMI) and operative
history, was recorded at admission. Exclusion criteria were
contraindications to any of the forms of medication used in the
study (oxycodone, ketoprofen, paracetamol), language difficulties
(inability to understand and speak Finnish or Swedish), diameter of
the cyst  10 cm or suspected malignancy detected by vaginal
sonography. The participants were randomly assigned to undergo
umbilical or lateral abdominal laparoscopic removal of an adnexal
mass. Randomization was carried out by means of opaque,
numbered envelopes, opened by a surgeon in the operating room
before the operation. Twenty-one women were randomized to theFig. 1. Flow diagram showing transumbilical (TU) group and 21 to the lateral transabdominal
(TA) group. Follow-up in both groups was six months. The study
design was approved by the local Ethics Committee of Helsinki and
Uusimaa district (98/13/03/03/2014) on 27 March 2014. This study
was registered at ClinicalTrials.gov (NCT02704663).
All operations were performed using a standardized anesthesi-
ology protocol. Every patient received 1 g paracetamol as
premedication. Standardized monitoring was used. Anesthesia
was induced and maintained with controlled infusion of propofol
and remifentanil. Tracheal intubation was facilitated with rocuro-
nium. The patients were ventilated with a mixture of oxygen in air.
To prevent postoperative nausea and vomiting all patients were
given dexamethasone (5 mg) at the start of anesthesia and
ondansetron (4 mg) with droperidol (0.1 mg/10 kg) at the end of
the operation. Every patient also received fentanyl (1 mg/kg) and
ketoprofen (100 mg) at the end of the procedure for pain control.
All the operations were performed by senior consultants with
the assistance of trainees or by trainees under the guidance of
senior consultants. All senior consultants were experienced
surgeons who had earlier mostly used lateral transabdominal
ports for retrieval of an adnexal mass. The patients were in the
lithotomy position. Pneumoperitoneum was achieved in all
patients via insertion of a Veress needle through the umbilicus.
In the TU group a 10-mm trocar for the 10-mm, 0 optical device
was inserted, and three 5-mm trocars in the left and right
paramedian and suprapubic regions were placed under direct
visualization. After cyst, ovary or adnexal extirpation, a “Teleflex”
Rush MemoBag (Picture 1) was introduced blindly into the
abdominal cavity through the umbilical port, after temporary
removal of the optics. The bag was then opened and the specimen
inserted. The bag was closed and the tip of the thread was pushed
with the same grasper to the umbilical port and out of the
abdominal cavity at the same time as the camera was pulled out.the study randomization.
Picture 1. a “Teleflex” Rush MemoBag. Picture 2. Endobag usea in lower transabdominal group.
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opened and the fluid removed by suction, after which the bag with
all remaining contents was removed. The fascia at the umbilicus
was closed under direct visual control with 0-Vicryl sutures using a
traditional needle holder. The fascias at the 5-mm incisions were
not closed. The skin incisions were closed with absorbable sutures.
At the end of the operation 20 ml of 7.5% ropivacain was infiltrated
to the trocar incisions, 5 ml to each.
The traditional protocol for removing adnexal masses in
laparoscopic gynecologic surgery in Finland has been the lateral
abdominal route. In the TA group a 10-mm umbilical trocar for the
10-mm, 0 optical device was inserted and another 10-mm trocar
in the left paramedian region with two 5-mm trocars in the right
paramedian and suprapubic regions were placed under direct
visualization. The adnexal mass was placed in an endobag with a
shaft (Covidien Endo Catch specimen retrieval pouch; Picture 2)
inserted through the left paramedian 10-mm port with an
introducer. The bag was removed through the same 10-mm
lateral abdominal incision. The fascia at the 10-mm lateral port
was closed with 0-Vicryl sutures using a Berci fascial closure
instrument. The fascia at the umbilicus was closed under direct
visual control with a 0-Vicryl single suture using a traditional
needle holder. The fascias at the 5-mm incisions were not closed.
Skin incisions were closed with absorbable sutures. At the end of
the operation 20 ml of 7.5% ropivacain was infiltrated to every
trocar incision, 5 ml to each.
In the post-anesthesia care unit postoperative pain was treated
with an intravenous dose of oxycodone (3 mg) if the visual analog
scale (VAS) score was 5. On the surgical ward every patient
received paracetamol (1 g/6 h) and ibuprofen (600 mg/6 h) if the
VAS score was 3, and an intramuscular dose of oxycodone (5 mg)
on request if the VAS score was 4 at rest. The total amount of
oxycodone was recorded from the end of surgery until discharge. In
addition, at 1, 3, 6, 12 and 24 h after surgery, the patients used VAS
scores to record the severity of their postoperative incisional pain,
0 indicating no pain and 10 indicating unbearable pain.VAS scores were used for estimating postoperative nausea
and vomiting over the same time periods. The length of hospital
stay was counted from the end of the operation until discharge.
All patients were sent a questionnaire six months postoperative-
ly in order to evaluate their recovery. Finally, the operating
gynecologists were asked (by email) about their preferred
surgical route.
Power calculation
Power calculation was based on a previous finding that the
median need for pain medication by oxycodone is 10 mg after
laparoscopic surgery for an adnexal mass during hospital stay [21].
The use of an umbilical endobag was assumed to reduce the
median oxycodone dose to 5 mg. With 80% power (a = 0.05), using
a two-sample t-test, 17 patients per group would be needed. A 10%
dropout rate was assumed and thus 20 patients were needed in
each group.
Statistical analysis
All analyses were performed with SPSS software, version 20
(IBM SPSS Inc., IL., USA). The results are presented as medians and
interquartile ranges (IQRs), or n (%). Differences in continuous
variables were analyzed by means of the Mann–Whitney U-test for
skewed data. Chi-square or Fisher‘s exact tests were used as
appropriate for independent nominal data. Statistical significance
was defined as p < 0.05.
Results
There were 21 women in each group; their demographic
characteristics are described in Table 1. There were no significant
differences between the groups.
The total dose of oxycodone used was similar in both groups:
6 mg (2.5–10) vs. 5.5 mg (0–10.8) in the TU and TA groups,
Table 1
Demographics of women undergoing laparoscopy for benign adnexal masses.
Variable Transumbilical group (n = 21) Lower lateral transabdominal group (n = 21) p-value
Age (years) 42 (35–56) 44 (29–56) 0.73
BMI (kg/m2) 25 (22–26) 25 (23–29) 0.36
Painkiller use 2 (9.5) 1 (5.0) 0.58
Previous surgery 11 (52.4) 9 (45.0) 0.63
ASA physical status 1 (1–2) 1 (1–2) 1
1 11 (52.4) 14 (70) 0.35
2 9 (4.9) 6 (30) 0.33
3 1 (4.8) – 0.31
Indications
Endometriosis 6 (29%) 7 (32%) 0.74
Dermoid cyst 4 (19%) 3 (15%) 0.68
Simplex cyst 7 (32%) 1 (5%) 0.02
Cystadenoma 2 (10%) 3 (14%) 0.63
Breast cancer 1 (5%) 5 (24%) 0.08
Sactosalpinx 1 (5%) 1 (5%) 1
Fibroma 0 1 (5%) 0.31
Data are presented as n (%) or median (interquartile range [IQR]).
Table 2
Use of oxycodone, pain (VAS scores) and time to discharge among the women undergoing laparoscopy.
Variable Transumbilical group Transabdominal group p-value
Postoperative pain (VAS score)
1 h 1.5 (0–8) 2 (0–8) 0.82
3 h 1 (0–4) 1 (0–7) 0.78
6 h 2 (0–5) 3 (0–8.5) 0.07
12 h 3 (0–8) 3 (0–8) 0.18
24 h 3 (0–7) 3 (0–7.5) 0.75
Max pain 4 (1–8) 4 (1–8.5) 0.62
VAS  7 3 (14.3%) 5 (23.8%) 0.43
VAS  4 8 (38.1%) 8 (38.1%) 1.00
VAS 0–1 during the first 12 h after operation 4 (19%) 0 (0%) 0.04
Time to discharge (min) 360 (180–1440) 345 (150–1080) 0.27
Oxycodone (mg) 6 (2.5–10) 5.5 (0–10.8) 0.64
Postoperative nausea and vomiting (VAS score) 0 0 –
Operative time (min) 70 (43–95) 80 (65–100) 0.076
Bleeding (ml) 0 (0–10) 0 (0–100) 0.16
Major complication 0 0
Data are presented as n (%) or median (interquartile range [IQR]).
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maximal pain did not differ statistically between the groups.
Postoperative pain scores were also analyzed to see whether there
were differences in severe pain (VAS 7) or low pain (VAS <4). No
significant differences in these values were found. However, thereTable 3
Questionnaire and related responses six months after operation.
Transumbilical group (n = 21) 
Response rate 15 (71%) 
Did you have any problems in the recovery period? N (response rate)
YES 4 (27%) 
NO 11 (63%) 
Are you satisfied with the cosmetic outcome of your operation? N (response rate)
YES 14 (93%) 
NO 1 (7%) 
Were you given sufficient sick-leave to recover properly? N (response rate)
YES 10 (67%) 
NO 5 (33%) 
For how many days did you need painkillers after your operation? Days (range)
6 (2–7) 
Would you have this operation again? N (response rate)
YES 15 (100%) 
NO 0 (0%) 
Would you recommend this operation to others? N (response rate)
YES 13 (87%) 
NO 2 (13%) was a difference between the groups when pain scores of 0–1
during the first 12 h after operation were analyzed (TA 0 [0%] vs. TU
4 [19.0%], p = 0.04). This difference was not due to increased use of
oxycodone because patients with lower pain scores received less
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scores for nausea or vomiting, operative bleeding, operative time,
major complications or postoperative satisfaction of patients.
Every gynecologic surgeon (n = 19) performing the procedures
preferred the transumbilical route.
Most of those women who completed a questionnaire six
months after surgery (33/35, 94%) were satisfied with the
operation and they would also recommend it to others. Two
patients, one in each group, were dissatisfied with the cosmetic
outcome. Altogether, 10 patients (24%) had minor problems
during the recovery period, but there was no difference between
the groups. In the TU group two patients experienced umbilical
wound secretion, one had a postoperative infection and one had a
hematoma in the area of the lateral port. In the TA group four
patients had pain in the lateral trocar region and two patients had
a hematoma in the lateral trocar area. During the follow-up
period no postoperative trocar hernias were found. The average
duration of pain medication in the TU group was six days, and in
the TA group, five days. A third of the patients in the TU group
wished for longer sick-leave to recover, vs. 25% in the TA group
(NS; Table 3).
Comments
This randomized study was planned to improve recovery after
laparoscopic surgery. Our hypothesis was that smaller incisions in
the lower abdominal wall and the use of an umbilical endobag
would reduce postoperative pain and need of opioids. The need of
oxycodone did not differ significantly between the groups. Also,
the median pain-VAS scores, scores of very intense pain (VAS 7)
or low pain (VAS <4) were not significantly different between the
groups. However, there were more patients in the TU group having
very low pain-VAS scores (VAS 0–1) during the first 12 h after
operation (TA 0 [0%] vs. TU 4 [19.0%], p = 0.04).
There are various reasons for our findings. Firstly, use of local
anesthesia in trocar incisions may have reduced pain effectively
[10,11] in both groups. Secondly, the use of oxycodone was lower
than expected and estimated in the power calculation; thus the
study may have been underpowered. However, use of the umbilical
port for adnexal mass removal was associated with a tendency
towards shorter operative times, made possible because of faster
and easier closure of the incision. It was also associated with more
women with very low pain-VAS scores during the first 12 h of
follow-up.
Importantly, we showed that the umbilical and abdominal
pathways of tissue removal were equally feasible and safe in
laparoscopic adnexal surgery. The amount of pain medication,
postoperative pain, and wound healing were similar in both groups
and no major complications occurred. There was no significant
difference in time to discharge or length of sick-leave. Patients
were equally satisfied with both methods. All gynecologic
surgeons performing the procedures preferred the transumbilical
route and this is now the routine method in our department for
laparoscopic specimen retrieval.
The strengths of our study were the randomized nature of the
trial and the strict control of pain and medication. Follow-up after
discharge enabled monitoring of late complications and recovery.
Recently, other investigators [22] assessed postoperative pain
after laparoscopic retrieval of benign adnexal tumors, with a
follow-up time of 24 h. Use of the transabdominal route caused
more immediate postoperative pain compared with the transum-
bilical route, but pain scores subsequently converged. They
concluded that removal of benign adnexal masses via an umbilical
port was associated with a shorter retrieval time and produced less
pain. Their study protocol differed from ours in port sites used and
inquiry about pain, and they did not report the amount of painmedication. In addition, unlike them, we infiltrated local anes-
thetic into port sites at the end of the operation. Despite many
methodological differences, their results are convergent with ours
as regards operation time, time to discharge, complication rate and
blood loss.
There are several options as regards the removal of tissues in
laparoscopy. The transvaginal route may be less painful than the
transumbilical route [17]. The transvaginal route has been
considered to be basically safe. However, it may carry a risk of
injury to adjacent organs such as the bowel, ureters or vagina and
may cause dyspareunia if the wound is scarred [23].
In gynecology as well as in other surgical specialities, an
attempt is made to minimize the size of abdominal incisions. The
benefits are decreased risks of wound infection, incisional hernias
and postoperative pain, a quicker return to normal life, improved
cosmetic results and greater patient satisfaction. During laparo-
scopic entry, trocar placement may cause abdominal wall blood
vessel and nerve injuries or hernias [12]. The risk is lower if smaller
trocars are used [4,7]. Transumbilical retrieval of specimens allows
the use of 5-mm secondary ports. Even if the umbilical incision is
widened during removal of the specimen, the risk of hernia seems
to be lower in umbilical vs. lateral abdominal trocar wounds [7].
Finally, umbilical incisions cause less pain than other abdominal
incisions in single-site surgery [20].
We conclude that in laparoscopic adnexal mass removal, both
routes are feasible and safe. The umbilical route could be
considered as the first option, because more women in the TU
group experienced only very low-level postoperative pain and this
route was the surgeons’ preference.
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